Evidence map›Paper›PMID 36341446›Full record

ArticleFrontiers in immunology2022

Fei Han, Muhammad Yaaseen Gulam, Yichao Zheng, Nurul Syuhada Zulhaimi, Wan Rong Sia, Dan He, Amanda Ho, Leila Hadadi, Zhenyu Liu, Peiwu Qin and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. The Emerging Role of MAIT Cell Responses in Viral Infections.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Fei HanInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Muhammad Yaaseen GulamProgramme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
Yichao ZhengInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Nurul Syuhada ZulhaimiCentre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia.
Wan Rong SiaProgramme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
Dan HeInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Amanda HoInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Leila HadadiProgramme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
Zhenyu LiuInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Peiwu QinInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Peter E LobieInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
Adeeba KamarulzamanCentre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia.
Lin-Fa WangProgramme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
Johan K SandbergCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Sharon R LewinPeter Doherty Institute for Infection and Immunity, Melbourne University, Victoria, Australia.
Reena RajasuriarCentre of Excellence for Research in AIDS (CERiA), University of Malaya, Kuala Lumpur, Malaysia.
Edwin LeeansyahInstitute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
National University of Singapore · SGTsinghua–Berkeley Shenzhen Institute · CNTsinghua University · CNUniversity of Malaya · MYKarolinska Institutet · SEPeter Doherty Institute · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MAIT cells are persistently depleted and functionally exhausted in HIV-1-infected patients despite long-term combination antiretroviral therapy (cART). IL-7 treatment supports MAIT cell reconstitution

Indexed as

HIV-1HIV InfectionsMucosal-Associated Invariant T CellsHumansInterleukin-7Polymorphism, Single NucleotideInterleukin-7antiretroviral (ARV) therapyCD127 (IL7Ra) geneHIV-1IL-7MAIT cells

Identifiers

PMID36341446
PMCPMC9632172
OpenAlexW4306874317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.